Eulexin Capsule
Product Images NDC 80725-143

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Eulexin (NDC 80725-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eulexin 01)

Chemical structure of flutamide, the active ingredient in Eulexin. The diagram shows a benzene ring substituted with trifluoromethyl and nitro groups, attached to a side chain containing an amide functional group.*

FDA Label Image

Principal Display Panel (125 mg Capsule Bottle Label)

Label for Eulexin 125 mg capsules, containing Flutamide USP. The label states 180 capsules per container. It highlights prescription use (Rx only) and instructs storage at 20° to 25°C (68° to 77°F). The labeler is Waylis Therapeutics LLC. Additional instructions about dosage, child safety, and dispensing are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.